Journal of American Academy of Dermatology
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
A 10-year population-based prevalence study of the burden of generalized pustular psoriasis in Canadian patients hospitalized or seen in emergency departments and hospital- or community-based outpatient clinics
2023
-
A 10-year population-based prevalence study of the burden of palmoplantar pustulosis in Canadian patients hospitalized or seen in emergency departments and hospital- or community-based outpatient clinics
2023
-
A 3-year population-based incidence study of the burden of generalized pustular psoriasis in Canadian patients hospitalized or seen in emergency departments and hospital- or community-based outpatient clinics
2023
-
A 3-year population-based incidence study of the burden of palmoplantar pustolosis in Canadian patients hospitalized or seen in emergency departments and hospital- or community-based outpatient clinics
2023
-
Racial and Ethnic Differences in Breslow Thickness by Melanoma Subtype Among Women
2023
-
Quantification of the area of affection and inflammation of hidradenitis suppurativa using a dedicated mobile app
2021
-
Long-term efficacy and safety of guselkumab in psoriasis patients with and without psoriatic arthritis: A pooled analysis from VOYAGE 1 and VOYAGE 2
2019
-
Secukinumab demonstrates significant improvement of disease activity and health-related quality of life in Canadian psoriasis patients in a real-world setting
2018
-
Sociodemographic and baseline disease profile of patients with moderate to severe chronic plaque psoriasis treated with secukinumab vs. other treatments in Canadian routine clinical care: Results from the PURE registry
2018
-
Early real-world effectiveness of secukinumab in the treatment of psoriasis in Canada: Retrospective analysis of patient support program data
2017
-
Secukinumab provides greater 52-week sustained relief from dermatology-related quality of life impact on clothing choice and sexual function than ustekinumab
2017
-
Secukinumab provides greater cumulative 52-week skin clearance and quality of life benefit in patients with moderate-to-severe plaque psoriasis than ustekinumab: An area under the curve analysis
2017
-
Comparison of guselkumab with placebo and adalimumab on health-related quality of life in a phase 2b clinical trial X-PLORE
2016
-
Major emotional and physical complications among survivors of Stevens Johnson syndrome and toxic epidermal necrolysis
2016
-
Cutaneous disease is associated with higher early systemic lupus disease activity
2015
-
Patient preferences and willingness to pay for enhancements to subcutaneous injection devices used to treat psoriasis
2014
-
A systematic review of patient-reported outcome instruments of nonmelanoma skin cancer in the dermatologic population
2013
-
Efalizumab's effectiveness in treating plaque psoriasis affecting the hands/feet, scalp, and nails: Interim subanalysis of the Canadian RESTORE study data
2009
-
A practical understanding of mean percent PASI reduction for biologics
2008
-
Infliximab-induced pustular psoriasis
2008
-
Palmoplantar keratoderma in a patient with a chromosome 12q deletion
2008
-
Similar responses with adalimumab therapy in patients with moderate versus severe psoriasis: Subanalysis of multiple placebo-controlled trials
2008
-
Approach to Mycosis Fungoides in children: Consensus-based recommendations..
91:1078-1085.
2024
-
Prevalence and risk factors of interstitial lung disease in dermatomyositis: A retrospective study..
91:1219-1221.
2024
-
53370 Understanding Burdens and Barriers to Dermatological Management, and Potential for Virtual Care in Northern and Rural Canadian Indigenous Communities: A National Healthcare Practitioner Cross-Sectional Survey Analysis.
91:ab349.
2024
-
Organic solvent exposure and systemic sclerosis: A retrospective cohort study based on the Canadian Scleroderma Research Group registry.
90:605-607.
2024
-
43266 A 10-year population-based prevalence study of the burden of generalized pustular psoriasis in Canadian patients hospitalized or seen in emergency departments and hospital- or community-based outpatient clinics.
89:AB106-AB106.
2023
-
43322 A 10-year population-based prevalence study of the burden of palmoplantar pustulosis in Canadian patients hospitalized or seen in emergency departments and hospital- or community-based outpatient clinics.
89:AB107-AB107.
2023
-
44100 A 3-year population-based incidence study of the burden of generalized pustular psoriasis in Canadian patients hospitalized or seen in emergency departments and hospital- or community-based outpatient clinics.
89:AB107-AB107.
2023
-
44118 A 3-year population-based incidence study of the burden of palmoplantar pustolosis in Canadian patients hospitalized or seen in emergency departments and hospital- or community-based outpatient clinics.
89:AB107-AB107.
2023
-
Hydrochlorothiazide use and risk of keratinocyte carcinoma and melanoma: A multisite population-based cohort study.
89:243-253.
2023
-
Management of adult generalized pustular psoriasis using biologics: A systematic review.
89:417-419.
2023
-
Geographical distribution of systemic sclerosis in Canada: An ecologic study based on the Canadian Scleroderma Research Group.
87:1095-1097.
2022
-
Reporting of primary outcome measures and sample size calculations in randomized controlled trials in dermatology journals.
87:912-914.
2022
-
Management of pediatric generalized pustular psoriasis using biologics: An evidence-based review.
87:484-486.
2022
-
26423 Psychometric properties of patient-reported outcome measures for nail conditions: A systematic review.
85:AB18-AB18.
2021
-
27591 Quantification of the area of affection and inflammation of hidradenitis suppurativa using a dedicated mobile app.
85:ab153.
2021
-
Trends in mortality and cause-specific mortality among patients with psoriasis and psoriatic arthritis in Ontario, Canada.
84:1302-1309.
2021
-
Brodalumab success in patients with moderate-to-severe psoriasis who failed previous interleukin-17A inhibitors.
84:1169-1171.
2021
-
Guselkumab dosing interval optimization in adult patients with psoriasis: A retrospective, multicenter case series.
83:1813-1814.
2020
-
Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderate-to-severe psoriasis through 2 years of treatment: Results from the CLEAR study.
81:1405-1409.
2019
-
Effect of secukinumab on quality of life and psoriasis-related symptoms: A comparative analysis versus ustekinumab from the CLEAR 52-week study.
78:741-748.
2018
-
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study.
76:60-69.e9.
2017
-
Treatment of toxic epidermal necrolysis in North America.
73:876-877.e2.
2015
-
Interleukin 17A: Toward a new understanding of psoriasis pathogenesis.
71:141-150.
2014
-
Stem cell transplantation in advanced cutaneous T-cell lymphoma.
58:645-649.
2008
-
Psoriasis of the nail: Anatomy, pathology, clinical presentation, and a review of the literature on therapy.
57:1-27.
2007
-
Prognostic factors for life expectancy in nonagenarians with nonmelanoma skin cancer: Implications for selecting surgical candidates.
47:419-422.
2002
-
Histologic features of actinic keratoses in solid organ transplant recipients and healthy controls..
45:217-221.
2001
-
Measuring quality of life in people referred for specialist care of acne: Comparing generic and disease-specific measures.
43:229-233.
2000
-
Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoides.
43:54-60.
2000
-
Cigarette smoking-associated elastotic changes in the skin..
41:23-26.
1999
-
Topical calcipotriol in childhood psoriasis.
36:203-208.
1997
-
The effects of chronic sunscreen use on the histologic changes of dermatoheliosis..
33:941-946.
1995
-
Human in vivo phosphorus 31 magnetic resonance spectroscopy of psoriasis. A noninvasive tool to monitor response to treatment and to study pathophysiology of the disease..
30:959-965.
1994
-
A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff.
29:1008-1012.
1993
-
Combined treatment with oral etretinate and electron beam therapy in patients with cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).
26:960-967.
1992
-
Actinic prurigo: Clinical features and prognosis.
26:683-692.
1992
-
Polymyositis: A manifestation of chronic graft-versus-host disease.
25:560-562.
1991
-
Serum sickness—like illness and leukocytoclastic vasculitis after intravenous streptokinase.
24:652-653.
1991
-
Langerhans cell histiocytosis in monozygotic twins.
24:32-37.
1991
-
HLA typing in actinic prurigo.
22:1019-1023.
1990
-
PRETIBIAL EPIDERMOLYSIS-BULLOSA - REPORT OF A CASE.
22:346-350.
1990
-
Pretibial epidermolysis bullosa: Report of a case.
22:346-350.
1990
-
Thyroid evaluation in alopecia areata in children.
19:1118-1118.
1988
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)